We are live on ! Find out more
STAB

Statera Biopharma, Inc. Common Stock
STAB

Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

41 hedge funds and large institutions have $7.62M invested in Statera Biopharma, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

379% more call options, than puts

Call options by funds: $532K | Put options by funds: $111K

Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
41
Increased
–
Reduced
–
Closed
–
Calls
$532K
Puts
$111K
Net Calls
+$421K
Net Calls Change
+$421K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
26
Cambridge Investment Research Advisors
Iowa
$24K +$26K +755 New
U
27
UBS
Switzerland
$21K +$22.3K +649 New
BA
28
BlackRock Advisors
Delaware
$18K +$19.1K +556 New
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$17K +$18.8K +545 New
KPCM
30
Kings Point Capital Management
New York
$16K +$17.2K +500 New
Citadel Advisors
31
Citadel Advisors
Florida
$10K +$10.7K +312 New
Wells Fargo
32
Wells Fargo
California
$9K +$9.26K +269 New
Bank of America
33
Bank of America
North Carolina
$8K +$8.44K +245 New
ECAM
34
East Coast Asset Management
Massachusetts
$8K +$8.61K +250 New
Citigroup
35
Citigroup
New York
$3K +$3.17K +92 New
RFC
36
Russell Frank Company
Washington
$3K +$3.17K +92 New
LFG
37
LifePlan Financial Group
Ohio
$3K +$3.44K +100 New
US Bancorp
38
US Bancorp
Minnesota
$3K +$3.44K +100 New
AIG
39
American International Group
New York
$790 +$861 +25 New
Ameriprise
40
Ameriprise
Minnesota
– +$103 +3 New
HF
41
Hoxton Financial
West Virginia
– +$516 +15 New
1
2

STAB Hedge Fund Activity: Q2 2013 in Review

41 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Statera Biopharma, Inc. Common Stock (STAB) for Q2 2013, worth a combined $7.62M.

Buyers outnumbered sellers: 41 funds opened new STAB positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

  • 41 institutional investors held Statera Biopharma, Inc. Common Stock (STAB) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $7.62M of Statera Biopharma, Inc. Common Stock stock for Q2 2013.
  • 41 funds opened new Statera Biopharma, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +41 holders.

Based on aggregated 13F filings for Q2 2013.